Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Ophthalmology and Therapy |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868847747101097984 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Ophthalmology and Therapy |
| description | |
| discipline_display | Ophthalmology and Optometry |
| discipline_facet | Ophthalmology and Optometry |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:94951 |
| institution | FRELIP |
| journal_source_facet | Ophthalmology and Therapy |
| last_indexed | 2026-06-24T03:34:57.471Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials Ophthalmology and Optometry General Ophthalmology and Optometry |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Ophthalmology and Optometry General Ophthalmology and Optometry |
| subject_facet | Ophthalmology and Optometry General Ophthalmology and Optometry |
| title | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials |
| title_alt | Resumen de investigación: Aflibercept 8 mg versus Faricimab tratar y extender para edema macular diabético o degeneración macular neovascular relacionada con la edad: un metanálisis en red de efectos fijos bayesiano de ensayos clínicos Résumé de recherche : Aflibercept 8 mg versus Faricimab treat-and-extend pour l'œdème maculaire diabétique ou la dégénérescence maculaire néovasculaire liée à l'âge : une méta-analyse en réseau à effets fixes bayésienne d'essais cliniques Resumo da Pesquisa: Aflibercept 8 mg versus Faricimab Tratar-e-Estender para Edema Macular Diabético ou Degeneração Macular Neovascular Relacionada à Idade: Uma Meta-análise de Rede de Efeito Fixo Bayesiana de Ensaios Clínicos |
| title_auth | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials |
| title_es_txt | Resumen de investigación: Aflibercept 8 mg versus Faricimab tratar y extender para edema macular diabético o degeneración macular neovascular relacionada con la edad: un metanálisis en red de efectos fijos bayesiano de ensayos clínicos |
| title_fr_txt | Résumé de recherche : Aflibercept 8 mg versus Faricimab treat-and-extend pour l'œdème maculaire diabétique ou la dégénérescence maculaire néovasculaire liée à l'âge : une méta-analyse en réseau à effets fixes bayésienne d'essais cliniques |
| title_full | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials |
| title_fullStr | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials |
| title_full_unstemmed | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials |
| title_pt_txt | Resumo da Pesquisa: Aflibercept 8 mg versus Faricimab Tratar-e-Estender para Edema Macular Diabético ou Degeneração Macular Neovascular Relacionada à Idade: Uma Meta-análise de Rede de Efeito Fixo Bayesiana de Ensaios Clínicos |
| title_short | Summary of Research: Aflibercept 8 mg versus Faricimab Treat‑and‑Extend for Diabetic Macular Edema or Neovascular Age‑Related Macular Degeneration: A Bayesian Fixed‑Effect Network Meta‑analysis of Clinical Trials |
| title_sort | summary of research: aflibercept 8 mg versus faricimab treat‑and‑extend for diabetic macular edema or neovascular age‑related macular degeneration: a bayesian fixed‑effect network meta‑analysis of clinical trials |
| topic | Ophthalmology and Optometry General Ophthalmology and Optometry |
| url | https://link.springer.com/article/10.1007/s40123-026-01434-w |